Article Information
- Received March 27, 1998
- Revision received June 25, 1998
- Accepted August 6, 1998
- First published October 15, 1998.
- Version of record published October 15, 1998.
Author Information
- T. M. DeLorey1,
- A. Handforth3,
- S. G. Anagnostaras2,
- G. E. Homanics4,
- B. A. Minassian3,
- A. Asatourian3,
- M. S. Fanselow2,
- A. Delgado-Escueta2,
- G. D. Ellison2, and
- R. W. Olsen1
- 1Departments of Molecular and Medical Pharmacology and
- 2Psychology, University of California, Los Angeles, California 90095, and
- 3Neurology Division, West Los Angeles Veteran’s Affairs Medical Center, Los Angeles, California 90073, and
- 4Department of Anesthesiology/Critical Care Medicine, University of Pittsburgh, Pennsylvania 15261
Author contributions
Disclosures
- Received March 27, 1998.
- Revision received June 25, 1998.
- Accepted August 6, 1998.
This work was supported by National Institute of Health Grant NS28772 to R.W.O., the Angelman Syndrome Foundation to R.W.O. and T.M.D., and by the University Anesthesiology and Critical Care Medicine Foundation and Grant AA10422 to G.E.H. We thank Dr. Robert Sparkes for helpful discussions. We also thank Carolyn Ferguson and Joanne Steinmiller for expert technical assistance, and Leonard Firestone for support and encouragement.
Correspondence should be addressed to Dr. Richard W. Olsen, Department of Molecular and Medical Pharmacology, University of California, Los Angeles, CA 90095.
Dr. DeLorey’s present address: Molecular Research Institute, 845 Page Mill Road, Palo Alto, CA 94304.
Dr. Minassian’s present address: Division of Neurology, Hospital for Sick Children, University of Toronto, Canada M5G 1X8.
Online Impact